.
1 H NMR spectrum of 1 2 Figure S2 .
13 C NMR spectrum of 1 3 Figure S3 . DEPT135 spectrum of 1 3 Figure S4 . HSQC spectrum of 1 4 Figure S5 . HMBC spectrum of 1 4 Figure S6 . NOESY spectrum of 1 5 Figure S7 . HRESIMS spectrum of 1 5 Figure S8 . IR spectrum of 1 6 Figure S9 .
1 H NMR spectrum of a mixture of 3 and 2 6 Figure S10 . 13 C NMR spectrum of a mixture of 3 and 2 7 Figure S11 . DEPT135 spectrum of a mixture of 3 and 2 7 Figure S12 . HSQC spectrum of a mixture of 3 and 2 8 Figure S13 . HMBC spectrum of a mixture of 3 and 2 8 Figure S14 . NOESY spectrum of 2 9 Figure S15 . HR-ESIMS spectrum of 7-carboxypenicitrinol C (2) 9 Figure S16 . IR spectrum of 7-carboxypenicitrinol C (2) 10 Figure S17 .
1 H NMR spectrum of 8 10 Figure S18 .
13 C NMR spectrum of 8 11 Figure S19 . DEPT135 spectrum of 8 11 Figure S20 . HMBC spectrum of 8 12 Figure S21 . HRESIMS spectrum of 8 12 Figure S22 . IR spectrum of 8 13 Figure S23 .
13 CNMR, DEPT135 spectra of 9 13 Figure S24 . HMBC spectrum of 9 14 Figure S25 . NOESY spectrum of 9 14 Figure S26 . HRESIMS spectrum of 9 15 Figure S27 . IR spectrum of 9 15 Figure S28 .
1 H NMR spectra of 10 and 11 16 Figure S29 .
13 C NMR, DEPT135 spectra of 10 and 11 17 Figure Figure S14. NOE spectrum of 7-carboxypenicitrinol C (2).
Figure S15. HR-ESIMS spectrum of 7-carboxypenicitrinol C (2).
Figure S16. IR spectrum of 7-carboxypenicitrinol C (2). 
S1. Enzyme Inhibitory Assay

S1.1. Cathepsin B Activity Assay
The assay was performed in 96-well plate according to a published method with modification. Brifely, 50 μL reaction buffer (100 mM sodium acetate (pH 5.5), 1 mM EDTA, 4 mM dithiothreitol) containing 0.0025 unit of cathepsin B from human liver (Sigma, one unit will liberate 1 nanomole of 7-amino-4-methylcoumarin from Z-Arg-Arg 7-amido-4-methylcoumarin per min at pH 6.0 at 40 °C) and 2 μL test compounds dissolved in DMSO were added to each well of a 96-well plate. After preincubation for 15 min at room temperature, 50 μL of reaction buffer containing 100 μM Z-Arg-Arg-7-amido-4-methylcoumarin (Sigma) was added and incubated for 30 min at room temperature. Fluorescence was measured using a microplate reader (Wallac 1420 Victor 2, PerkinElmer, HolIand) with an excitation of 355 nm and emission at 460 nm.
S1.2. IMPDH Enzyme Assay
His-taged human IMPDH П was recombinantly expressed in Escherichia coli and purified by Ni-NTA affinity chromotagraphy as described previously. The IMPDH activity assay was performed in 200-μL assay volume of 96-well plate. Briefly, 2 μL of test compound (dissolved in DMSO) or DMSO and 150 μL enzyme buffer containing 100 mM KH 2 PO 4 , 0.5 mM EDTA pH 8, and 2 mM dithiothreitol and 50 nM IMPDH were added into the plate and incubated at 37 °C for 15 min. The reaction was initiated by adding 50 μL reaction buffer containing a final concentration of 200 μM inosine 5-monophosphate (Sigma) and 200 μM NAD (Sigma). The OD was read at 340 nm after incubation at 37 °C for 30 min with a microplate reader (Wallac 1420 Victor 2, PerkinElmer, HolIand).
S1.3. PTP1B and SHP2 Activity Assays
Human recombinant PTP1B and SHP2 were expressed in E. coli and purifed by Ni-NTA affinity chromotagraphy in our laboratory, respectively. The enzyme activity was measured using p-nitrophenyl phosphate (pNPP) as substrate in a 96-well plate. Brifely, purified recombinant PTP1B or SHP2 (0.05 μg) in 50 μL buffer containing 50 mM citrate (pH 6.0), 0.1 M NaCl, 1 mM EDTA, and 1 mM dithiothreitol (DTT) and test compounds were added to each well of a 96-well plate. After preincubation for 15 min at room temperature, 50 μL of reaction buffer containing 2 mM pNPP was added and incubated at 37 °C for 30 min. The PTP1B or SHP2 activity was measured by detecting the absorbance at 405 nm for the amount of produced p-nitrophenol.
S2. Larval Settlement Bioassays
Antifouling activity of compounds was evaluated in settlement inhibition assays with laboratory-reared B. neritina larvae. Larval settlement bioassays were performed using sterile 24-well polystyrene plates as previously reported. Briefly, the stock solution of tested samples in DMSO was diluted with autoclaved filtered sea water (FSW) to concentrations ranging from 1 to 300 ppm. Then the EC 50 and LC 50 values of active compounds were calculated. In this way, about 20 competent larvae were added to each well in 1 mL of the test solution. Wells containing only FSW with DMSO served as the controls. Three replicates of each treatment were used. The plates were incubated at 27 °C for 1 h. The percentage of larval settlement was determined by counting the settled, live individuals under a dissecting microscope and expressing the result as a proportion of the total number of larvae in the well. EC 50 (inhibits 50% of settlement of B. neritina larvae in comparison with the control) and LC 50 (refers to the concentration that kills 50% of the test organisms in comparison with the control) levels of active compounds were calculated by using the Excel software program.
